A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients Whose Disease is Resistant or Refractory to T-DM1, and/or T-DXd, and/or Tucatinib-containing Regimens

  • McCartney, Amelia (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description


StatusActive
Effective start/end date8/07/21 → 7/08/26

Keywords

  • phase 2 study
  • breast cancer
  • treatment efficacy
  • treatment safety
  • cancer treatment